Burgin KE - Search Results

1

Whole tumor cell vaccine with irradiated S180 cells as adjuvant.

Li J, King AV, Stickel SL, Burgin KE, Zhang X, Wagner TE, Wei Y. Li J, et al. Among authors: burgin ke. Vaccine. 2009 Jan 22;27(4):558-64. doi: 10.1016/j.vaccine.2008.11.014. Epub 2008 Nov 21. Vaccine. 2009. PMID: 19027812

2

Transfer of in vitro expanded T lymphocytes after activation with dendritomas prolonged survival of mice challenged with EL4 tumor cells.

Li J, Theofanous L, Stickel S, Bouton-Verville H, Burgin KE, Jakubchak S, Wagner TE, Wei Y. Li J, et al. Among authors: burgin ke. Int J Oncol. 2007 Jul;31(1):193-7. Int J Oncol. 2007. PMID: 17549421

3

Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study.

Wei YC, Sticca RP, Li J, Holmes LM, Burgin KE, Jakubchak S, Bouton-Verville H, Williamson J, Meyer K, Evans L, Martin J, Stephenson JJ, Trocha S, Smith S, Wagner TE. Wei YC, et al. Among authors: burgin ke. Oncol Rep. 2007 Sep;18(3):665-71. Oncol Rep. 2007. PMID: 17671717

4

Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity.

Li J, Holmes LM, Franek KJ, Burgin KE, Wagner TE, Wei Y. Li J, et al. Among authors: burgin ke. Cancer Immunol Immunother. 2001 Nov;50(9):456-62. doi: 10.1007/s002620100218. Cancer Immunol Immunother. 2001. PMID: 11761439

5

Glycoinositol phospholipid-anchored interleukin 2 but not secreted interleukin 2 inhibits melanoma tumor growth in mice.

Ji J, Li J, Holmes LM, Burgin KE, Yu X, Wagner TE, Wei Y. Ji J, et al. Among authors: burgin ke. Mol Cancer Ther. 2002 Oct;1(12):1019-24. Mol Cancer Ther. 2002. PMID: 12481424

6

Targeting foreign major histocompatibility complex molecules to tumors by tumor cell specific single chain antibody (scFv).

Li J, Franek KJ, Patterson AL, Holmes LM, Burgin KE, Ji J, Yu X, Wagner TE, Wei Y. Li J, et al. Among authors: burgin ke. Int J Oncol. 2003 Nov;23(5):1329-32. Int J Oncol. 2003. PMID: 14532973

7

Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor.

Li J, Ji J, Holmes LM, Burgin KE, Barton LB, Yu X, Wagner TE, Wei Y. Li J, et al. Among authors: burgin ke. Cancer Gene Ther. 2004 May;11(5):363-70. doi: 10.1038/sj.cgt.7700707. Cancer Gene Ther. 2004. PMID: 15044960

8

Inhibition or promotion of tumor growth by granulocyte-macrophage colony stimulating factor derived from engineered tumor cells is dose-dependent.

Li J, Bouton-Verville H, Holmes LM, Burgin KE, Jakubchak S, Yu X, Wagner TE, Wei Y. Li J, et al. Among authors: burgin ke. Anticancer Res. 2004 Sep-Oct;24(5A):2717-21. Anticancer Res. 2004. PMID: 15517877 Free article.

9

Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses.

Wei Y, Sticca RP, Holmes LM, Burgin KE, Li J, Williamson J, Evans L, Smith SJ, Stephenson JJ, Wagner TE. Wei Y, et al. Among authors: burgin ke. Int J Oncol. 2006 Mar;28(3):585-93. Int J Oncol. 2006. PMID: 16465362 Clinical Trial.

10

Fermented Noni exudate (fNE): a mediator between immune system and anti-tumor activity.

Li J, Stickel SL, Bouton-Verville H, Burgin KE, Yu X, Wong DK, Wagner TE, Wei Y. Li J, et al. Among authors: burgin ke. Oncol Rep. 2008 Dec;20(6):1505-9. Oncol Rep. 2008. PMID: 19020734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page